Cargando…
Overexpression of PD-L1 is an Independent Predictor for Recurrence in HCC Patients Who Receive Sorafenib Treatment After Surgical Resection
OBJECTIVE: The predicting values of programmed cell death protein 1 (PD-1) and programmed death-ligand 1(PD-L1) were unclear in Hepatocellular carcinoma (HCC) patients who receive sorafenib treatment after curative hepatic resection. METHODS: We retrospectively enrolled HCC patients who received adj...
Autores principales: | Tan, Yifei, Xu, Qing, Wu, Zhenru, Zhang, Wei, Li, Bo, Zhang, Bohan, Xu, Xi, Zhang, Bo, Yan, Ke, Song, Jiulin, Lv, Tao, Yang, Jian, Jiang, Li, Shi, Yujun, Yang, Jiayin, Yan, Lunan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804345/ https://www.ncbi.nlm.nih.gov/pubmed/35117990 http://dx.doi.org/10.3389/fonc.2021.783335 |
Ejemplares similares
-
Outcomes of anterior approach major hepatectomy with diaphragmatic resection for single huge right lobe HCC with diaphragmatic invasion
por: Zheng, Jinli, et al.
Publicado: (2018) -
Efficacy and safety of anatomic resection versus nonanatomic resection in patients with hepatocellular carcinoma: A systemic review and meta-analysis
por: Tan, Yifei, et al.
Publicado: (2017) -
HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation
por: Yuan, Jingsheng, et al.
Publicado: (2022) -
Liver resection associated with better outcomes for single large hepatocellular carcinoma located in the same section
por: Zhang, Wei, et al.
Publicado: (2017) -
TKI or TKI combined with PD-1 inhibitors as second-line treatment for HCC patients after sorafenib failure
por: Lei, Jin, et al.
Publicado: (2022)